Theoretical model for the diclofenac release from PEGylated chitosan hydrogels

Drug Deliv. 2021 Dec;28(1):261-271. doi: 10.1080/10717544.2021.1876181.

Abstract

Controlled drug delivery systems are of utmost importance for the improvement of drug bioavailability while limiting the side effects. For the improvement of their performances, drug release modeling is a significant tool for the further optimization of the drug delivery systems to cross the barrier to practical application. We report here on the modeling of the diclofenac sodium salt (DCF) release from a hydrogel matrix based on PEGylated chitosan in the context of Multifractal Theory of Motion, by means of a fundamental spinor set given by 2 × 2 matrices with real elements, which can describe the drug-release dynamics at global and local scales. The drug delivery systems were prepared by in situ hydrogenation of PEGylated chitosan with citral in the presence of the DCF, by varying the hydrophilic/hydrophobic ratio of the components. They demonstrated a good dispersion of the drug into the matrix by forming matrix-drug entities which enabled a prolonged drug delivery behavior correlated with the hydrophilicity degree of the matrix. The application of the Multifractal Theory of Motion fitted very well on these findings, the fractality degree accurately describing the changes in hydrophilicity of the polymer. The validation of the model on this series of formulations encourages its further use for other systems, as an easy tool for estimating the drug release toward the design improvement. The present paper is a continuation of the work 'A theoretical mathematical model for assessing diclofenac release from chitosan-based formulations,' published in Drug Delivery Journal, 27(1), 2020, that focused on the consequences induced by the invariance groups of Multifractal Diffusion Equations in correlation with the drug release dynamics.

Keywords: Multifractal Theory of Motion; PEGylated chitosan; diclofenac sodium salt; drug release; lie groups.

MeSH terms

  • Acyclic Monoterpenes
  • Chitosan*
  • Diclofenac / administration & dosage
  • Diclofenac / pharmacokinetics*
  • Drug Delivery Systems
  • Drug Liberation*
  • Hydrogels*
  • Hydrogenation
  • Models, Chemical
  • Models, Theoretical*
  • Polyethylene Glycols*

Substances

  • Acyclic Monoterpenes
  • Hydrogels
  • Diclofenac
  • Polyethylene Glycols
  • Chitosan
  • citral

Grants and funding

The research leading to these results has received funding from the Romanian National Authority for Scientific Research, MEN-UEFISCDI grant, project number PN-III-P1-1.2-PCCDI2017-0569 (10PCCDI/2018).